Our Media & Newsroom serves as a vital resource, offering insights and updates that keep our community informed. Explore key developments, important announcements, and resources that elevate our mission.
Welcome to the official media hub of the DSHEA Preservation Alliance. Here, journalists, researchers, and stakeholders can access reliable information, timely updates, and expert perspectives on the policies, challenges, and successes shaping the future of dietary supplement regulation. Whether you’re covering legal developments, tracking FDA activity, or exploring DSHEA’s impact on public health and innovation, our newsroom offers curated resources to support your work. Browse our press releases, statements, and recent headlines—or reach out directly for customized support. We’re here to ensure clarity, credibility, and context in every story.
The Wall Street Journal reported on the booming longevity industry and the regulatory challenges faced by companies marketing NMN supplements. The article highlights the dispute
A federal court mandated the FDA to halt enforcement actions against NMN vendors and required the agency to address the NPA’s pending citizen petition. This decision
The NPA hailed the court’s decision to stay the NMN lawsuit as a “monumental victory,” emphasizing that the FDA exceeded its authority and must adhere
A federal court granted a joint motion filed by the NPA and FDA to stay proceedings in the NMN lawsuit, pending the FDA’s response to
The Natural Products Association (NPA) filed a lawsuit challenging the FDA’s determination that NMN is excluded from the definition of a dietary supplement due to
The FDA announced that β-nicotinamide mononucleotide (β-NMN) is not a legal dietary ingredient, citing its prior investigation as a drug. The Council for Responsible Nutrition (CRN)
The Wall Street Journal reported on the booming longevity industry and the regulatory challenges faced by companies marketing NMN supplements. The article highlights the dispute between supplement companies and pharmaceutical firms over NMN’s classification and the FDA’s stance on its legality as a dietary supplement.
A federal court mandated the FDA to halt enforcement actions against NMN vendors and required the agency to address the NPA’s pending citizen petition. This decision provides temporary relief to NMN supplement manufacturers and consumers.
The NPA hailed the court’s decision to stay the NMN lawsuit as a “monumental victory,” emphasizing that the FDA exceeded its authority and must adhere to the law’s provisions. The ruling allows NMN supplements to remain on the market while the FDA reviews the citizen petition.
A federal court granted a joint motion filed by the NPA and FDA to stay proceedings in the NMN lawsuit, pending the FDA’s response to the NPA’s citizen petition. The FDA indicated it would respond to the petition by July 31, 2025, and would not prioritize enforcement actions against NMN
The Natural Products Association (NPA) filed a lawsuit challenging the FDA’s determination that NMN is excluded from the definition of a dietary supplement due to its prior investigation as a drug. The NPA argues that the FDA’s retroactive application of the law is unlawful and harms the dietary supplement industry.
The FDA announced that β-nicotinamide mononucleotide (β-NMN) is not a legal dietary ingredient, citing its prior investigation as a drug. The Council for Responsible Nutrition (CRN) responded, expressing concern that this decision stifles innovation and disregards consumer interests.
For all media requests or press inquiries related to the DSHEA or the DSHEA Preservation Alliance, please get in touch with us at [email protected]. We’re happy to assist journalists, researchers, and media professionals with timely information, expert insights, and background materials.
Subscribe to receive the latest updates on DSHEA enforcement, regulatory developments, research insights, and advocacy efforts—curated for policymakers, health professionals, industry leaders, and researchers.
The DSHEA Preservation Alliance is dedicated to defending the integrity of the Dietary Supplement Health and Education Act (DSHEA). We advocate for lawful FDA enforcement, protect the legal distinction between supplements and drugs, and promote regulatory clarity that supports innovation, safety, and consumer trust. Through education, outreach, and policy engagement, we work to preserve the framework that empowers responsible access to supplements and protects public health.
Helpful Links
LET'S CHAT!
Visit
444 N. Capitol Street NW
Suite 840
Washington, DC 20001
© 2025 DSHEA Preservation Alliance
